Maravai LifeSciences Earnings
NASDAQ: MRVIHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Thu, Nov 5, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.08
Maravai LifeSciences earnings summary
Maravai LifeSciences is scheduled to report Sep/2026 earnings on Nov 5, 2026, with analysts expecting EPS of $-0.08. In its most recent report on Aug 7, 2026 (Q2 2026), MRVI posted EPS of $-0.08. Revenue for the quarter was $51.4 million.
Across the last 16 reports, MRVI shares moved an average of 8.3% (in either direction) in the first trading session after results, rising 8 times and falling 8 times.
Summary generated from market data by MetaCap's automated system. Methodology
MRVI earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 7, 2026 | — | $-0.08 | — | -8.5% |
| May 8, 2026 | — | $-0.02 | — | -14.4% |
| Feb 26, 2026 | — | $-0.24 | — | -0.3% |
| Nov 7, 2025 | — | $-0.18 | — | +26.8% |
| Aug 11, 2025 | — | $-0.27 | — | -6.1% |
| May 12, 2025 | — | $-0.21 | — | +5.7% |
| Mar 18, 2025 | — | $-0.21 | — | +4.2% |
| Nov 12, 2024 | — | $-0.68 | — | +18.1% |
| Aug 8, 2024 | — | $-0.07 | — | +13.3% |
| May 9, 2024 | — | $-0.09 | — | +8.2% |
| Feb 29, 2024 | — | $-0.80 | — | +1.1% |
| Nov 8, 2023 | — | $-0.05 | — | -2.1% |
| Aug 8, 2023 | — | $-0.05 | — | -2.2% |
| May 9, 2023 | — | $0.00 | — | -9.8% |
| Feb 28, 2023 | — | $0.30 | — | -11.0% |
| Nov 4, 2022 | — | $0.34 | — | +1.2% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.